| EGFR | Epidermal growth factor receptor |
| GBM | Glioblastoma multiforme |
| ECM | Extracellular matrix |
| IDH | Isocitrate dehydrogenase |
| VEGF | Vascular endothelial growth factor receptor |
| EGF | Epidermal growth factor |
| FGF | Fibroblast growth factor |
| MMP | Matrix metalloprotease |
| MAPK | Mitogen-activated protein kinase |
| PI3K | Phosphoinositide 3-kinase |
| GSC | Glioma stem-like cells |
| ERK | Extracellular-signal regulated kinase |
| uPA | Urokinase-type plasminogen activator |
| tPA | Tissue-type plasminogen activator |
| PAI | Plasminogen activator inhibitors |
| uPAR | Urokinase-type plasminogen activator receptor |
| PLCγ | Phospholipase Cγ |
| TGFα | Transforming growth factor |
| EGFL7 | EGF-like domain-containing protein 7 |
| Grb2 | Grb2 Growth factor receptor-bound protein 2 |
| PTEN | Phosphatase and tensin homolog |
| SFK | Src family kinase |
| JAK | Receptor-associated Janus kinase |
| PIP2 | Phosphatidylinositol-4,5-bisphosphate |
| mTOR | Mammalian target of rapamycin |
| GSK3 | Glycogen synthase kinase 3 |